GIVEN IMAGING LTD
			Symbol			GIVN

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Given Imaging to Host November 23rd Meeting and Webcast to Discuss New Features of PillCam(R) COLON2 and Review Results From Israeli Feasibility Trial

2009-11-02 16:01 ET - News Release

YOQNEAM, ISRAEL -- (MARKET WIRE) -- 11/02/09

Given Imaging Ltd. (NASDAQ: GIVN), the global leader in capsule endoscopy, today announced that it will host a meeting with members of the financial community to discuss new features of the company's second-generation PillCam® COLON and review results from the recently completed Israeli feasibility study. The meeting will take place on Monday, November 23rd at the Novotel London ExCel Hotel, Western Gateway, Royal Victoria Dock, E16 1AA, London, UK. The meeting will begin at 2:00pm London Time, 9:00am New York Time, and 4pm Israel Time.

Speakers will include:

--  Homi Shamir, President and CEO of Given Imaging
--  Prof. Rami Eliakim, Rambam Medical Center and Prof. Sam Adler, Bikkur
    Holim Hospital, principal investigators from the PillCam COLON2 feasibility
    trial who will review results
--  Prof. Jacques Devière, Erasme Hospital, Brussels will discuss the need
    for alternatives to colonoscopy in Europe
    

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.